Pomerantz LLP Appointed Lead Counsel in Yang v. Nobilis Health Corp. Securities Litigation
Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against Nobilis Health Corporation.
Read MorePomerantz LLP was appointed lead counsel in a class action lawsuit filed against Nobilis Health Corporation.
Read MorePomerantz achieved a significant victory for investors in Fiat Chrysler on September 5, when U.S. District Judge Jesse M. Furman granted final approval to a $110 million settlement with the automaker. “Counsel has secured a substantial recovery for the class,” the judge said …
Read MorePomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Ascena Retail Group, Inc.
Read MorePomerantz LLP was appointed Lead Counsel in a class action lawsuit against 22nd Century Group on behalf of investors.
Read MorePomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Nabriva Therapeutics.
Read MorePomerantz LLP was appointed Lead Counsel in a securities litigation class action against Boston Scientific Corporation.
Read MorePomerantz LLP was appointed Lead Counsel in a securities class action lawsuit on behalf of investors against AT&T Inc.
Read MorePomerantz LLP was appointed Co-Lead Counsel in a class action law suit filed against Credit Suisse Group AG on behalf of investors in VelocityShares Daily Inverse VIX MediumTerm exchange-traded notes.
Read MoreOn June 10, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action law suit filed against CenturyLink, Inc..
Read MoreOn June 5, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit filed against McDermott International.
Read MorePomerantz’s recently filed intervention motion in a New Jersey federal court litigation marks the first court test of the legality of mandatory shareholder arbitration.
Read MoreOn March 28, 2019, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against WuXi PharmaTech (Cayman) Inc. (“WuXi” or the “Company”) and certain of its officers and directors.
Read MorePomerantz LLP was appointed Co-Lead Counsel in a class action law suit filed against CVS Health Corporation.
Read MorePomerantz LLP was appointed lead counsel in a class action lawsuit filed against Aveo Pharmaceuticals.
Read MorePomerantz LLP was appointed lead counsel in a class action lawsuit filed against YRC Worldwide, Inc.
Read MorePomerantz LLP was ranked #1 in both Total Settlement Amount and Number of Settlements for 2018 by SCAS.
Read MorePomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Bellicum Pharmaceuticals, Inc.
Read MorePomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Allergan plc.
Read MorePomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Ormat Technologies, Inc.
Read MorePomerantz LLP was appointed Co-Lead Counsel in a class action lawsuit filed against Philip Morris International Inc.
Read More